News

Every month, thousands of women thwart abortion bans in their home states by turning to telehealth clinics willing to ...
The move follows an announcement by Secretary Robert F. Kennedy Jr. that the FDA will be conducting a review of mifepristone.
Amid a quiet legislative session for health, lawmakers’ priority legislation reinforced the U.S. health secretary’s agenda.
Below, check out the roundup of California Healthline’s coverage. For today's national health news, read KFF Health News’ Morning Briefing.
Opponents of President Donald Trump ’s administration are set to rally in hundreds of cities on Saturday during the military ...
Kennedy’s decision to “retire” the previous 17-member panel was widely decried by doctors’ groups and public health ...
The Minnesota House’s top Democrat helped shepherd a package of liberal initiatives to passage when her party had a narrow ...
We're a nonprofit (so it's tax-deductible), and reader support makes up about two-thirds of our budget. In late March, the US ...
President Donald Trump's administration this week provided deportation officials with personal data — including the immigration status — on millions of Medicaid enrollees, a move that could make ...
CALLING THE MOVE “legally dubious” and an “abuse,” Gov. Gavin Newsom on Friday heavily criticized the Trump administration ...
Health and Human Services Secretary Robert F. Kennedy Jr.'s announcement that the agency will no longer recommend COVID-19 vaccines for healthy children, adults under 65 or pregnant women shocked the ...